Preemptive oral ganciclovir therapy versus prophylaxis to prevent symptomatic cytomegalovirus infection after kidney transplantation

被引：29
|
作者：
Jung, C [1 ]
Engelmann, E [1 ]
Borner, K [1 ]
Offermann, G [1 ]
机构：
[1] Free Univ Berlin, Klinikum Benjamin Franklin, Inst Klin Chem & Pathobiochem, Inst Infektionsmed,Med Klin 4, D-12200 Berlin, Germany
来源：
TRANSPLANTATION PROCEEDINGS | 2001年 / 33卷 / 7-8期
关键词：
D O I：
10.1016/S0041-1345(01)02558-1
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：3621 / 3623
页数：3
相关论文
共 50 条
  • [1] Preemptive therapy for cytomegalovirus with oral ganciclovir after liver transplantation
    Singh, N
    [J]. TRANSPLANTATION, 2002, 73 (12) : 1977 - 1977
  • [2] Valacyclovir prophylaxis versus preemptive valganciclovir therapy to prevent cytomegalovirus disease after renal transplantation
    Reischig, T.
    Jindra, P.
    Hes, O.
    Svecova, M.
    Klaboch, J.
    Treska, V.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (01) : 69 - 77
  • [3] Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation
    Reusser, P
    Einsele, H
    Lee, J
    Volin, L
    Rovira, M
    Engelhard, D
    Finke, J
    Cordonnier, C
    Link, H
    Ljungman, P
    [J]. BLOOD, 2002, 99 (04) : 1159 - 1164
  • [4] Oral valganciclovir versus intravenous ganciclovir as preemptive treatment for cytomegalovirus infection after living donor liver transplantation: A randomized trial
    Togashi, Junichi
    Sugawara, Yasuhiko
    Hashimoto, Masao
    Tamura, Sumihito
    Kaneko, Junichi
    Aoki, Taku
    Hasegawa, Kiyoshi
    Kokudo, Norihiro
    [J]. BIOSCIENCE TRENDS, 2011, 5 (05) : 217 - 222
  • [5] Oral Valganciclovir Versus Intravenous Ganciclovir as Preemptive Treatment for Cytomegalovirus Infection after Living Donor Liver Transplantation: A Randomized Trial
    Togashi, J.
    Sugawara, Y.
    Hashimoto, M.
    Tamura, S.
    Kaneko, J.
    Aoki, T.
    Sakamoto, Y.
    Hasegawa, K.
    Kokudo, N.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 254 - 254
  • [6] Oral versus intravenous ganciclovir for the prophylaxis of cytomegalovirus disease after allogeneic bone marrow transplantation
    Szer, J
    Durrant, S
    Schwarer, AP
    Bradstock, KF
    Gibson, J
    Arthur, C
    To, LB
    Hughes, T
    Raunow, H
    [J]. INTERNAL MEDICINE JOURNAL, 2004, 34 (03) : 98 - 101
  • [7] Preemptive therapy versus universal prophylaxis with ganciclovir for cytomegalovirus in solid organ transplant recipients
    Singh, N
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 32 (05) : 742 - 751
  • [8] Antiviral Prophylaxis Versus Preemptive Therapy to Prevent Cytomegalovirus Infection and Related Death in Liver Transplantation: A Retrospective Study With Propensity Score Matching
    Kim, S. I.
    Kim, C. J.
    Kim, Y. J.
    Son, H.
    Kim, Y. E.
    Kim, M. S.
    Hwang, S.
    Kim, J. I.
    You, Y. K.
    Kim, D. G.
    Kang, M. W.
    [J]. TRANSPLANTATION PROCEEDINGS, 2012, 44 (03) : 787 - 790
  • [9] Effect of oral acyclovir or ganciclovir therapy after preemptive intravenous ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus seropositive renal and liver transplant recipients receiving antilymphocyte antibody therapy
    Turgeon, N
    Fishman, JA
    Basgoz, N
    Tolkoff-Rubin, NE
    Doran, M
    Cosimi, AB
    Rubin, RH
    [J]. TRANSPLANTATION, 1998, 66 (12) : 1780 - 1786
  • [10] Impact of ganciclovir prophylaxis on cytomegalovirus infection in cadaveric kidney vs combined kidney and pancreas transplantation
    Peddi, VR
    Hariharan, S
    Munda, R
    Schroeder, TJ
    First, MR
    [J]. TRANSPLANTATION PROCEEDINGS, 1995, 27 (06) : 3076 - 3077
12345